JNJ Operating Cash Flow (Statement)

Johnson & Johnson · Operating Cash Flow (Statement)

JNJ logo

JNJ Operating Cash Flow (Statement)

Latest reported$23.70B
JNJ TTM Cash from Operations ($1.66B → $23.70B)
High-resolution chart · PNG

JNJ operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Johnson & Johnson Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
23,703,000,000
22,870,000,000
24,530,000,000
24,204,000,000
23,028,000,000
24,783,000,000
24,266,000,000
25,146,000,000
24,642,000,000
23,191,000,000
22,791,000,000
20,278,000,000
19,073,000,000
20,472,000,000
21,194,000,000
21,576,000,000
23,582,000,000
23,315,000,000
23,410,000,000
26,021,000,000
26,114,000,000
24,252,000,000
23,536,000,000
21,591,000,000
20,735,000,000
23,231,000,000
23,416,000,000
23,262,000,000
22,007,000,000
22,138,000,000
22,201,000,000
22,062,000,000
22,056,000,000
21,749,000,000
21,056,000,000
21,604,000,000
20,699,000,000
19,917,000,000
18,767,000,000
17,196,000,000
17,960,000,000
18,170,000,000
19,279,000,000
18,562,000,000
17,091,000,000
17,420,000,000
18,471,000,000
18,245,000,000
19,538,000,000
19,060,000,000
17,414,000,000
16,651,000,000
15,201,000,000
14,878,000,000
15,396,000,000
15,471,000,000
15,596,000,000
14,777,000,000
14,298,000,000
14,671,000,000
15,083,000,000
15,011,000,000
16,385,000,000
17,848,000,000
17,908,000,000
17,434,000,000
16,571,000,000
15,285,000,000
15,084,000,000
14,563,000,000
14,972,000,000
15,295,000,000
14,593,000,000
14,648,000,000
15,249,000,000
15,208,000,000
15,152,000,000
14,611,000,000
14,248,000,000
13,148,000,000
13,020,000,000
12,678,000,000
11,839,000,000
11,117,000,000
10,999,000,000
11,111,000,000
11,131,000,000
12,222,000,000
11,683,000,000
11,214,000,000
10,595,000,000
9,170,000,000
8,376,000,000
8,277,000,000
8,176,000,000
8,845,000,000
8,431,000,000
9,139,000,000
8,832,000,000
7,285,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.